Cargando…

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient

Detalles Bibliográficos
Autores principales: Jehn, Ulrich, Altuner, Ugur, Pavenstädt, Hermann, Reuter, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/
https://www.ncbi.nlm.nih.gov/pubmed/36262114
http://dx.doi.org/10.3389/ti.2022.10846
_version_ 1784810989319880704
author Jehn, Ulrich
Altuner, Ugur
Pavenstädt, Hermann
Reuter, Stefan
author_facet Jehn, Ulrich
Altuner, Ugur
Pavenstädt, Hermann
Reuter, Stefan
author_sort Jehn, Ulrich
collection PubMed
description
format Online
Article
Text
id pubmed-9573942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95739422022-10-18 First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient Jehn, Ulrich Altuner, Ugur Pavenstädt, Hermann Reuter, Stefan Transpl Int Health Archive Frontiers Media S.A. 2022-10-03 /pmc/articles/PMC9573942/ /pubmed/36262114 http://dx.doi.org/10.3389/ti.2022.10846 Text en Copyright © 2022 Jehn, Altuner, Pavenstädt and Reuter. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Health Archive
Jehn, Ulrich
Altuner, Ugur
Pavenstädt, Hermann
Reuter, Stefan
First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title_full First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title_fullStr First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title_full_unstemmed First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title_short First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
title_sort first report on successful conversion of long-term treatment of recurrent atypical hemolytic uremic syndrome with eculizumab to ravulizumab in a renal transplant patient
topic Health Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573942/
https://www.ncbi.nlm.nih.gov/pubmed/36262114
http://dx.doi.org/10.3389/ti.2022.10846
work_keys_str_mv AT jehnulrich firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient
AT altunerugur firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient
AT pavenstadthermann firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient
AT reuterstefan firstreportonsuccessfulconversionoflongtermtreatmentofrecurrentatypicalhemolyticuremicsyndromewitheculizumabtoravulizumabinarenaltransplantpatient